그린생명과학

114450KOSDAQ기초 의약물질 제조업

56.5 / 100

Reference Date: 2026-04-13

Financial Score23.0 / 40

News Sentiment12.5 / 25

Momentum9.0 / 20

Disclosure12.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Slightly down 1.4% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Green Life Science is a precision chemical materials company specializing in the development, production, and sale of pharmaceutical raw materials, intermediates, electronic materials, and crop protection agents. It has established a stable supply system through CMO (Contract Manufacturing Organization) partnerships with multinational corporations and is expanding its electronic materials business, including semiconductor and QLED materials, to meet industry growth trends.

Number of Employees

63people

Average Salary

66.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

451.67Industry Average 33.450.0Point

13.5x industry avg (risky)

PBR

1.42Industry Average 2.035.5Point

Lower than industry avg (good)

ROE

0.30Industry Average -4.293.5Point

Well below industry avg

Debt Ratio

1.48Industry Average 6.618.0Point

Half of industry avg (excellent)

Trend 2023~20256.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲36.7% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲31.2% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -10.8% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position5.0Point

52w mid range (45%)

Current 2,710Won52-week high 4,06552-week low 1,589

1-month return3.0Point

1m -1.45% (flat)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

5 totalPositive 1Neutral 4Negative 0

Neutral정기주주총회결과2026-03-27
Neutral사업보고서 (2025.12)2026-03-19
Neutral감사보고서제출2026-03-19
Neutral[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동2026-03-18
Positive단일판매ㆍ공급계약체결2026-03-17